Replies to post #284601 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Hi longfellow,

I am ready to join you in trying to estimate the survival of Treatment vs. Placebo/control at OS24, OS36 and OS60.

It will take me some time to present my best estimates. Intuitively I believe that OS36 is the easiest to estimate since we have the blended data of the 2018 JTM publication, the November 2018 SNO update as well as the earlier February 2017 75% progression information.

Based on that data, estimating the OS60 results seems somewhat more difficult but still doable.

Interestingly, of the 3 timelines, the OS24 will probably constitute the toughest challenge.